Cambrex Corp. (CBM) Tops Q3 EPS by 6c; FY16 Outlook Increased

Cambrex Corp. (NYSE: CBM) reported Q3 EPS of $0.47, $0.06 better than the analyst estimate of $0.41. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $96.07 million.

The Company increased its financial guidance for full year sales and Adjusted EBITDA. The Company expects full year 2016 sales, excluding the impact of foreign currency, to increase between 12% and 14% compared to 2015. The Company expects Adjusted EBITDA to be between $147 and $151 million, a 14% to 17% increase compared to 2015 (see Financial Expectations – Continuing Operations section below).

For earnings history and earnings-related data on Cambrex Corp. (CBM) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c